UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis

Molecular cancer, 2018-07, Vol.17 (1), p.98-98

2018

Volltextzugriff (PDF)

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Nature communications, 2022-05, Vol.13 (1), p.3011-10, Article 3011

2022

Volltextzugriff (PDF)

Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13), p.3605-3618

2017

Volltextzugriff (PDF)

Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer

Nature immunology, 2021-07, Vol.22 (7), p.865-879

2021

Volltextzugriff (PDF)

Blocking the recruitment of naive CD4＋ T cells reverses immunosuppression in breast cancer

Cell research, 2017-04, Vol.27 (4), p.461-482

2017

Volltextzugriff (PDF)

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

Journal for immunotherapy of cancer, 2020-05, Vol.8 (1), p.e000696

2020

Volltextzugriff (PDF)

Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5

Clinical cancer research, 2011-11, Vol.17 (22), p.7105-7115

2011

Volltextzugriff (PDF)

Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival

PloS one, 2013-05, Vol.8 (5), p.e63516-e63516

2013

Volltextzugriff (PDF)

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors

Science China. Life sciences, 2023, Vol.66 (1), p.94-109

2023

Volltextzugriff (PDF)

Landscape of somatic alterations in large-scale solid tumors from an Asian population

Nature communications, 2022-07, Vol.13 (1), p.4264-4264, Article 4264

2022

Volltextzugriff (PDF)

miR-21 Induces Myofibroblast Differentiation and Promotes the Malignant Progression of Breast Phyllodes Tumors

Cancer research (Chicago, Ill.), 2014-08, Vol.74 (16), p.4341-4352

2014

Volltextzugriff (PDF)

Nanoparticles (NPs)‐Meditated LncRNA AFAP1‐AS1 Silencing to Block Wnt/β‐Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy

Advanced science, 2020-09, Vol.7 (18), p.2000915-n/a

2020

Volltextzugriff (PDF)

Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study

Breast cancer research : BCR, 2023-11, Vol.25 (1), p.1-132, Article 132

2023

Volltextzugriff (PDF)

Isolation and characterization of spheroid cells from the HT29 colon cancer cell line

International journal of colorectal disease, 2011-10, Vol.26 (10), p.1279-1285

2011

Volltextzugriff (PDF)

Markers of tumor-initiating cells predict chemoresistance in breast cancer

PloS one, 2010-12, Vol.5 (12), p.e15630-e15630

2010

Volltextzugriff (PDF)

Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single‐cell RNA sequencing

MedComm (2020), 2024-03, Vol.5 (3), p.e471-n/a

2024

Volltextzugriff (PDF)

HGF-induced PKCζ activation increases functional CXCR4 expression in human breast cancer cells

PloS one, 2012, Vol.7 (1), p.e29124

2012

Volltextzugriff (PDF)

Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking

PloS one, 2012-06, Vol.7 (6), p.e38403-e38403

2012

Volltextzugriff (PDF)

Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers

Clinical and translational medicine, 2020-06, Vol.10 (2), p.e92-n/a

2020

Volltextzugriff (PDF)

NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death

Nature immunology, 2018-10, Vol.19 (10), p.1112-1125

2018

Volltextzugriff (PDF)

Prognostic Value of Survivin and Livin in Nasopharyngeal Carcinoma

The Laryngoscope, 2006-01, Vol.116 (1), p.126-130

2006

Volltextzugriff (PDF)

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

The lancet oncology, 2023-08, Vol.24 (8), p.925-935

2023

Volltextzugriff (PDF)

Multifunctional sharp pH-responsive nanoparticles for targeted drug delivery and effective breast cancer therapy

Journal of materials chemistry. B, Materials for biology and medicine, 2019-01, Vol.7 (4), p.576-585

2019

Volltextzugriff (PDF)

A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma

Journal of personalized medicine, 2023-03, Vol.13 (3), p.476

2023

Volltextzugriff (PDF)

Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value

BioMed research international, 2015-01, Vol.2015 (2015), p.1-13

2015

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation

Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer

Blocking the recruitment of naive CD4＋ T cells reverses immunosuppression in breast cancer

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5

Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors

Landscape of somatic alterations in large-scale solid tumors from an Asian population

miR-21 Induces Myofibroblast Differentiation and Promotes the Malignant Progression of Breast Phyllodes Tumors

Nanoparticles (NPs)‐Meditated LncRNA AFAP1‐AS1 Silencing to Block Wnt/β‐Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy

Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study

Isolation and characterization of spheroid cells from the HT29 colon cancer cell line

Markers of tumor-initiating cells predict chemoresistance in breast cancer

Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single‐cell RNA sequencing

HGF-induced PKCζ activation increases functional CXCR4 expression in human breast cancer cells

Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking

Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers

NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death

Prognostic Value of Survivin and Livin in Nasopharyngeal Carcinoma

Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Multifunctional sharp pH-responsive nanoparticles for targeted drug delivery and effective breast cancer therapy

A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma

Long Noncoding RNA Expression Signatures of Metastatic Nasopharyngeal Carcinoma and Their Prognostic Value

Aktive Filter

Suchergebnisse filtern